Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The study will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat ascending doses of GSK2018682. The study will also provide further evidence of the potential therapeutic dose-range by measuring the inhibitory effect of GSK2018682 on Absolute Lymphocyte Counts (ALC).
Epistemonikos ID: 7d13d9ab5c04b18897b02c5b4f2fb9dfe06a0d67
First added on: Mar 31, 2022